XNASTLGY
Market cap110mUSD
Dec 06, Last price
11.64USD
Name
TLGY Acquisition Corp
Chart & Performance
Profile
TLGY Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on targets in biopharma or technology enabled business-to-consumer industries worldwide. The company was incorporated in 2021 and is based in Wilmington, Delaware.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY |
---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | |
Income | |||
Revenues | |||
Cost of revenue | 1,726 | 1,383 | 2,255 |
Unusual Expense (Income) | |||
NOPBT | (1,726) | (1,383) | (2,255) |
NOPBT Margin | |||
Operating Taxes | (13,029) | ||
Tax Rate | |||
NOPAT | (1,726) | 11,646 | (2,255) |
Net income | 3,446 -86.04% | 24,675 1,040.89% | 2,163 |
Dividends | |||
Dividend yield | |||
Proceeds from repurchase of equity | (178,439) | 236,744 | |
BB yield | |||
Debt | |||
Debt current | 1,292 | 111 | 111 |
Long-term debt | |||
Deferred revenue | |||
Other long-term liabilities | 9,003 | 9,102 | 19,830 |
Net debt | 1,251 | (238,086) | (236,053) |
Cash flow | |||
Cash from operating activities | (1,270) | (868) | (691) |
CAPEX | |||
Cash from investing activities | 176,619 | (234,600) | |
Cash from financing activities | (175,894) | 236,744 | |
FCF | (1,231) | 11,646 | |
Balance | |||
Cash | 41 | 585 | 1,453 |
Long term investments | 237,501 | 234,600 | |
Excess cash | 41 | 238,086 | 236,053 |
Stockholders' equity | 55,165 | 228,905 | 216,659 |
Invested Capital | 65,419 | 9,102 | 19,830 |
ROIC | 80.50% | ||
ROCE | |||
EV | |||
Common stock shares outstanding | 15,144 | 28,750 | 28,750 |
Price | 10.26 | ||
Market cap | 294,975 | ||
EV | 56,889 | ||
EBITDA | (1,726) | (1,383) | (2,255) |
EV/EBITDA | |||
Interest | 26,058 | ||
Interest/NOPBT |